Philip MacNeill Chief Financial Officer Dear Philip:Pharmathene, Inc • January 19th, 2017 • Pharmaceutical preparations • Maryland
Company FiledJanuary 19th, 2017 Industry JurisdictionOn behalf of PharmAthene, Inc. (“Company”), I am pleased to provide you with this letter agreement (“Agreement”) setting forth the various terms and conditions of a retention arrangement which the Company is prepared to offer you effective immediately. As explained herein, although you will remain an “at-will” employee, the Company has agreed to pay you certain bonuses for remaining employed through certain milestones described below. During your employment, you will be paid at your current salary rate.